Gotham Asset Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.25M | Buy |
39,707
+16,544
| +71% | +$523K | 0.01% | 1072 |
|
2025
Q1 | $769K | Sell |
23,163
-27,339
| -54% | -$907K | 0.01% | 1084 |
|
2024
Q4 | $1.74M | Sell |
50,502
-16,220
| -24% | -$558K | 0.02% | 751 |
|
2024
Q3 | $2.67M | Sell |
66,722
-18,283
| -22% | -$731K | 0.03% | 653 |
|
2024
Q2 | $2.56M | Buy |
85,005
+1,277
| +2% | +$38.5K | 0.03% | 610 |
|
2024
Q1 | $2.81M | Buy |
83,728
+1,530
| +2% | +$51.4K | 0.04% | 545 |
|
2023
Q4 | $2.65M | Buy |
82,198
+18,334
| +29% | +$592K | 0.05% | 507 |
|
2023
Q3 | $2.09M | Sell |
63,864
-8,838
| -12% | -$290K | 0.04% | 534 |
|
2023
Q2 | $2.56M | Buy |
72,702
+44,969
| +162% | +$1.58M | 0.06% | 473 |
|
2023
Q1 | $905K | Buy |
+27,733
| New | +$905K | 0.02% | 781 |
|
2022
Q4 | – | Sell |
-19,684
| Closed | -$872K | – | 1255 |
|
2022
Q3 | $872K | Buy |
+19,684
| New | +$872K | 0.03% | 697 |
|